Iterum Therapeutics plc (ITRM)
Market Open
31 Mar, 20:00
NASDAQ (CM) NASDAQ (CM) Primary OTC PINK $
0. 03
-0
-10.9792%
$
1.6M Market Cap
- P/E Ratio
- Div Yield
49.3M Volume
-2.35 Eps
$ 0.03
Previous Close Investors:
Want to track ITRM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Iterum Therapeutics plc (ITRM) Statistics
Valuation metrics
Market Cap 1.6M
Enterprise value 25.4M
Trailing P/E (ttm) -0.08
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 6.83
Price/Book (mrq) -0.31
Enterprise Value/Revenue 65.12
Enterprise Value/EBITDA -1.1
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 159.78K
Average volume (90 days) 17.12M
Price summary
52-Week low 0.03
52-Week high 1.42
Beta -
50-Day moving average 0.04
200-Day moving average 0.22
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:15
Last split Date 18 Aug 2022
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -69.13%
Operating margin -52.03%
Operational effectiveness
Return on assets -0.83%
Return on equity 6.02%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.01
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.59
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.24
Total debt (mrq) -
Total Debt/Equity (mrq) -4.57
Current ratio (mrq) 2.13%
Book value per share (mrq) -0.16
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
